期刊文献+

诺扬复合咪达唑仑在高血压患者全麻拔管期的临床应用观察 被引量:2

Effects of butorphanol combined with midazolam on anesthesia extubation in patients with hypertension
下载PDF
导出
摘要 目的观察诺扬复合咪达唑仑对全麻高血压患者气管拔管时心血管反应及术后不良反应的预防作用。方法选择全身麻醉的高血压患者60例,随机分为对照组(I组)、诺扬组(II组)及诺扬+咪达唑仑组(III组),三组麻醉诱导及维持方式相同。拔管前分别予0.9%等体积生理盐水,0.02mg/kg诺扬,0.01mg/kg诺扬+0.02mg/kg咪达唑仑。记录各时点SBP、DBP、HR、SpO2,比较各组拔管时间、术后不良反应。结果 II、III组患者围术期SBP、DBP、HR、SpO2变化平稳,明显优于I组,恶心呕吐、躁动的发生率也少于I组(P<0.05)。拔管时间I、II组无统计学差异,但均短于III组(P<0.05)。结论高血压患者在拔除气管导管前给予诺扬复合咪达唑仑能有效预防气管拔管时的心血管反应,且不良反应少。 Objective To observe the prevention effects of combination using of butorphanol and midazolam on anthesia extubation induced cardiovascular and postoperation adverse reaction.Methods 60 patients with primary hypertension were divided into 3 groups at random,controlled group(I group),butorphanol group(II group) and butorphanol combined with midazolam group(III group),and used the same method of anesthesia induction and maintenance among 3 groups.Before extubation,the 0.9% normal saline,butorphanol 0.02mg/kg and butorphanol 0.01mg/kg combined with midazolam 0.02mg/kg were injected respectively for the 3 groups.The parameters of SBP、DBP、HR、SpO2,extubation time and postoperative side effects were recorded.Results The extubation SBP、DBP、HR、SpO2 of group II and group III were keeping more stable than group I(P<0.05).The number of patients with nausea and vomiting,restlessness in group I was more than other 2 groups.Extubation time between group I and II were not statistically significant but all shorter than group III(P<0.05).Conclusion using of butorphanol and midazolam in patients with hypertension can effectively prevent tracheal extubation induced cardiovascular response and with less adverse reactions.
出处 《四川医学》 CAS 2012年第11期1941-1943,共3页 Sichuan Medical Journal
关键词 酒石酸布托啡诺 咪达唑仑 气管拔管期 心血管不良反应 butorphanol tartrate midazolam tracheal extubation cardiovascular adverse reactions
  • 相关文献

参考文献5

二级参考文献18

  • 1邓立琴,丁风兰,刘红.全麻术后躁动225例分析[J].实用医学杂志,2006,22(2):165-167. 被引量:291
  • 2杨春艳,宋宇龙,白宁.氯诺昔康与曲马多超前镇痛在腹腔镜胆囊切除术术后镇痛的对比观察[J].陕西医学杂志,2006,35(10):1303-1304. 被引量:11
  • 3Wood PL. Multiple opiate receptors; support for unique mu, deltaand kappa sites[J]. Neuropharmacology, 1982,21 (6) : 487 -497.
  • 4Vickers MD,O'Flaherty D,Szekely SM,et al. Tramadol- pain relief by an opioid without depression of respiration[J]. Anaesthesia, 1992,47 (4) : 291-296.
  • 5Duntcman E, KaranikolasM, FilosKS. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines[J]. J Pain SymptomManage, 1996,12(4) : 255- 260.
  • 6Vogelsan J,Hayes SR.Butorphanol tartrate (stadol):a review.J Post Anesth Nurs,1991,6(2):129.
  • 7Chu C C,Chen J Y,Chen C S,et al.The efficacy and safety of transnasal Butorphanol for postoperative pain control following lower laparoscopic surgery.Acts Anaesthesiol Taiwan,2004,42 (4):203.
  • 8Bailey P L,Egan T D,Stanley T H.Intravenous opioid anesthetics.See Miler R D.Anesthesia.5th ed.Philadelphia:Churchill Livingstone,2000.273-376.
  • 9Thomson IR,Harding G,Hudson RJ.A comparison of fentanyl and sufentanil in patients undergoing coronary artery bypass graft surgery. Journal of Cardiology . 2000
  • 10纪维,陆康生,夏德国.布托啡诺对全麻患者术后拔管期躁动的预防[J].四川医学,2007,28(11):1279-1280. 被引量:9

共引文献8

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部